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ncreased oxidative stress in vascular smooth muscle cells (VSMCs) enhances VSMC migration 1 and proliferation. 2 In fact, intracellular oxidative stress plays an important role in growth factor-mediated signal transduction and VSMC migration. 3 In addition, increased migration and proliferation of VSMCs may lead to enhanced atherosclerosis. 1 A critical linkage therefore exists among oxidative stress, migration, and atherosclerosis.
At least 5 dopamine receptor subtypes have been cloned from the brain. Types D 1A and D 1B are D 1 -like, whereas types D 2 , D 3 , and D 4 are D 2 -like. 4 Furthermore, D 1A receptors have been detected in coronary artery VSMCs, 5 and D 1 -like receptors have been evaluated biochemically. 6 We recently demonstrated that D 1 -like receptors inhibit migration and proliferation of VSMCs, possibly through activation of protein kinase A (PKA) and suppression of protein kinase C (PKC), suggesting that D 1 -like receptors have an antiatherosclerotic effect. 7 The present study was therefore designed to investigate the role of D 1 -like receptors in platelet-derived growth factor (PDGF)-mediated increase in oxidative stress in VSMCs and to examine the potential therapeutic effect of D 1 -like receptor agonists on atherosclerosis.
Methods

Cell Culture
VSMCs were grown from explants of 14-week-old normotensive Wistar rat renal arteries. Cells were identified as VSMCs on the basis of their morphological and immunohistochemical characteristics as previously reported. 7 
Immunohistochemistry
Antibodies against D 1A and D 1B dopamine receptors were purchased from Calbiochem, Inc. Polyclonal antibodies were raised against 2 synthetic peptide sequences: For light microscopic immunohistochemistry, VSMCs were cultured in slides until confluence. The VSMCs were washed in PBS and then incubated for 30 minutes with 3% normal goat serum and 1% nonfat dry milk in PBS and were incubated overnight at 4°C with one of the following: (1) D 1A receptor primary antiserum, (2) D 1B receptor antiserum, or (3) preadsorption serum. After washes in PBS, immunostaining was detected with an avidin-biotin immunoperoxidase reaction (Vectastain ABC Kit, Vector Laboratories) and visualized with diaminobenzidine (Fast DAB tablets, Sigma Chemical Co) or the peroxidase chromogen method (AEC Kit, Beomeda Co). For double staining with D 1A /D 1B receptors, the following incubations were performed in the indicated order: D 1A receptor antibody, biotinylated goat anti-rabbit immunoglobulin (DAKO), immuno-staining detection and visualization with DAB and nickel (black); and D 1B receptor antibody, biotinylated goat anti-rabbit immunoglobulin, immunostaining detection and visualization by AEC (red).
Immunoblotting
Immunoblotting was performed as previously described. 7 
Migration Assay
Migration of VSMCs was assayed by a modification of a Boyden's chamber method as previously reported. 7 
Assay of Intracellular Oxidative Stress
Intracellular oxidative stress levels were measured with carboxydichlorofluorescein diacetate bis-acetoxymethyl (AM) ester (Molecular Probes) as previously reported. 8 
Antisense Oligonucleotides
Phosphothioate-modified oligodeoxynucleotides for the rat D 1A and D 1B receptors were designed as reported 9, 10 These oligodeoxynucleotides were added to serum-free DMEM 24 hours before the start of PDGF-BB stimulation with transfection by cationic compound; lipofectin reagent (Gibco BRL) and oligonucleotides were effectively taken up by VSMCs.
Statistical Methods
Statistical analysis was performed by ANOVA and Scheffé's modified t test. 11 Values of PϽ0.05 were considered significant. Figure 
Results
Immunohistochemistry
Effects of D 1 -Like Receptor Agonists on VSMC Migration Stimulated by PDGF
The effects of the D 1 -like receptor agonists dopamine, SKF 38393, and YM 435 7 on the migration of VSMCs treated with PDGF-BB for 4 hours are shown in Figure 2 . D 1 -like receptor agonists inhibited PDGF-BB-induced VSMC migration.
Effects of D 1 -Like Receptor Agonists on Oxidative Stress Stimulated by PDGF
The effects of dopamine, SKF 38393, and YM 435 on oxidative stress in VSMCs treated with PDGF-BB for 4 hours are shown in Figure 3A . D 1 -like receptor agonists significantly inhibited PDGF-BB-induced increase in oxidative stress. Representative flow cytometry results are shown in Figure 3B . 
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Inhibition of Effects of Dopamine by D 1 -Like Antagonist Sch 23390
The specific D 1 -like antagonist Sch 23390 alone had no effect on oxidative stress (data not shown) but significantly reversed the dopamine-induced decrease in oxidative stress ( Figure 3A ).
Possible Involvement of PKA in Oxidative Stress in VSMCs Stimulated by PDGF
Forskolin 1 mol/L or 8-bromo-cAMP 100 mol/L reduced PDGF-BB-induced increase in oxidative stress ( Figure 4A ). Figure 4A ). Representative flow cytometry results are shown in Figure 4B .
PDGF-BB (
Effects of D 1 -Like Agonists on Phenylephrine-or Angiotensin II-Induced Increase in Oxidative Stress in VSMCs
Dopamine 10 mol/L prevented migration ( Figure 5A ) and the increase in oxidative stress ( Figure 5B ) induced through ␣ 1 -or angiotensin II AT 1 receptors. Receptor specificities were confirmed by use of prazosin, a specific ␣ 1 -antagonist, and losartan, a specific angiotensin II AT 1 receptor antagonist.
Inhibition of D 1 -Like Receptor Activation by Antisense Oligonucleotides
Antisense oligonucleotides to both D 1A and D 1B receptors at 5 mol/L inhibited the dopamine-induced suppression of increase in oxidative stress induced by PDGF. However, neither sense nor scrambled oligonucleotides to D 1A and D 1B receptors at 5 mol/L had significant effects (Figure 6 ). This study demonstrated that D 1 -like agonists inhibit oxidative stress in VSMCs stimulated with PDGF-BB through both D 1A and D 1B receptors (Figures 3 and 6) . Dopamine is readily oxidized and therefore has direct radical-scavenging effects. 12 However, the finding that D 1A and D 1B antisense oligonucleotides and the PKA inhibitor H 89 reduced the antioxidative effects of dopamine suggests that the antioxidative effect of dopamine is, at least in part, mediated by a D 1 -like receptor-mediated pathway. It has been reported that D 1 -like receptors coupled to adenylate cyclase on rat VSMCs possess a thiol group at or near the agonist binding site and that the oxidation of a thiol group of D 1 -like receptors inhibits their activation. 13 However, dopamine itself activated PKA, 7 which decreased oxidative stress ( Figure 4A ), suggesting that the dopamine acting at D 1 -like receptors in this study was not totally oxidized.
Dose-dependent responses to D 1 -like receptor agonists showed that suppression of VSMC migration and oxidative stress was present at 0.025 mol/L (Table) , which is 25 times higher than the normal plasma concentrations. This concentration is observed in humans in pathophysiological conditions. 14, 15 At present, we have no direct in vivo evidence that dopamine has an impact on atherogenesis. However, functional ablation of the D 1A receptor gene produced diastolic hypertension in mice, 16 and pathophysiological levels of dopamine may also decrease blood pressure. 14, 15 Therefore, the blood pressure-lowering effect of dopamine in vivo may affect atherosclerosis in vivo.
We have already demonstrated that PDGF-BB enhances VSMC migration and proliferation through PLD, PKC, and mitogen-activated protein kinase activation. 7 It has been reported that PLD and PKC play important roles in oxidative stress. 2, 8 We examined the effects of inhibitors of PLD or PKC and found that PLD and PKC play important roles in mediating the increased oxidative stress induced by PDGF-BB (Figure 4) .
We demonstrated that angiotensin II and phenylephrine increased oxidative stress through AT 1 and ␣ 1 -receptors, respectively. D 1 -like receptor agonists also prevented the increase in oxidative stress induced by angiotensin II and phenylephrine. Interestingly, dopamine, which is the precursor of norepinephrine, an ␣ 1 -agonist, antagonizes ␣ 1 -mediated effects through D 1 -like receptors, suggesting that dopamine may act in the third peripheral catecholamine system. 17 It is also interesting that dopamine antagonizes angiotensin II, which plays an important role in vascular remodeling, 18 suggesting the possibility of local interaction between dopamine receptors and the renin-angiotensin system. Because activation of D 1A receptors in rat juxtaglomerular cells has been reported to increase renin release, 9 this dopamine antagonism of angiotensin II effects may be a feedback mechanism responding to increased renin release.
In conclusion, our findings indicate that D 1 -like receptor agonists suppress PDGF-BB-mediated increase in oxidative stress through D 1A and D 1B receptors by activating PKA and suppressing PLD and PKC activities. 
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